Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice.
The ubiquitous Epstein-Barr virus (EBV) is the primary cause of infectious mononucleosis and is etiologically linked to the development of several malignancies and autoimmune diseases. EBV has a multifaceted life cycle that comprises virus lytic replication and latency programs. Considering EBV infe...
Main Authors: | Dwain G van Zyl, Ming-Han Tsai, Anatoliy Shumilov, Viktor Schneidt, Rémy Poirey, Bettina Schlehe, Herbert Fluhr, Josef Mautner, Henri-Jacques Delecluse |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-12-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1007464 |
Similar Items
-
Progress in EBV Vaccines
by: Dwain G. van Zyl, et al.
Published: (2019-02-01) -
Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines
by: Ashish C. Shrestha, et al.
Published: (2019-04-01) -
Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice.
by: Olga Antsiferova, et al.
Published: (2014-08-01) -
The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells.
by: Xiaochen Lin, et al.
Published: (2015-12-01) -
Some effects of cytolytic antibody
by: Rigby, Charlotte
Published: (2014)